![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HOXA10 |
Gene summary for HOXA10 |
![]() |
Gene information | Species | Human | Gene symbol | HOXA10 | Gene ID | 3206 |
Gene name | homeobox A10 | |
Gene Alias | HOX1 | |
Cytomap | 7p15.2 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P31260 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3206 | HOXA10 | HTA11_3410_2000001011 | Human | Colorectum | AD | 6.00e-08 | 1.79e-01 | 0.0155 |
3206 | HOXA10 | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.89e-04 | 1.62e-01 | -0.1808 |
3206 | HOXA10 | HTA11_1938_2000001011 | Human | Colorectum | AD | 2.86e-06 | 3.09e-01 | -0.0811 |
3206 | HOXA10 | HTA11_78_2000001011 | Human | Colorectum | AD | 2.65e-10 | 2.84e-01 | -0.1088 |
3206 | HOXA10 | HTA11_347_2000001011 | Human | Colorectum | AD | 6.17e-17 | 3.40e-01 | -0.1954 |
3206 | HOXA10 | HTA11_3361_2000001011 | Human | Colorectum | AD | 5.46e-03 | 1.46e-01 | -0.1207 |
3206 | HOXA10 | HTA11_83_2000001011 | Human | Colorectum | SER | 1.79e-04 | 1.77e-01 | -0.1526 |
3206 | HOXA10 | HTA11_696_2000001011 | Human | Colorectum | AD | 4.28e-10 | 2.47e-01 | -0.1464 |
3206 | HOXA10 | HTA11_866_2000001011 | Human | Colorectum | AD | 9.55e-09 | 2.01e-01 | -0.1001 |
3206 | HOXA10 | HTA11_1391_2000001011 | Human | Colorectum | AD | 7.96e-09 | 2.74e-01 | -0.059 |
3206 | HOXA10 | HTA11_5212_2000001011 | Human | Colorectum | AD | 3.97e-04 | 2.15e-01 | -0.2061 |
3206 | HOXA10 | HTA11_7862_2000001011 | Human | Colorectum | AD | 4.79e-05 | 2.52e-01 | -0.0179 |
3206 | HOXA10 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.85e-21 | 4.54e-01 | 0.096 |
3206 | HOXA10 | HTA11_4255_2000001011 | Human | Colorectum | SER | 3.40e-02 | 2.22e-01 | 0.0446 |
3206 | HOXA10 | HTA11_7663_2000001011 | Human | Colorectum | SER | 6.81e-04 | 2.31e-01 | 0.0131 |
3206 | HOXA10 | HTA11_10623_2000001011 | Human | Colorectum | AD | 4.46e-06 | 3.17e-01 | -0.0177 |
3206 | HOXA10 | HTA11_10711_2000001011 | Human | Colorectum | AD | 4.64e-04 | 1.44e-01 | 0.0338 |
3206 | HOXA10 | HTA11_7696_3000711011 | Human | Colorectum | AD | 8.94e-11 | 2.41e-01 | 0.0674 |
3206 | HOXA10 | HTA11_6818_2000001011 | Human | Colorectum | AD | 7.64e-12 | 5.04e-01 | 0.0112 |
3206 | HOXA10 | HTA11_6818_2000001021 | Human | Colorectum | AD | 3.33e-11 | 4.49e-01 | 0.0588 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00451374 | Thyroid | ATC | development of primary sexual characteristics | 97/6293 | 227/18723 | 2.47e-03 | 1.14e-02 | 97 |
GO:00303262 | Thyroid | ATC | embryonic limb morphogenesis | 52/6293 | 116/18723 | 7.67e-03 | 3.00e-02 | 52 |
GO:00351132 | Thyroid | ATC | embryonic appendage morphogenesis | 52/6293 | 116/18723 | 7.67e-03 | 3.00e-02 | 52 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa052028 | Esophagus | ESCC | Transcriptional misregulation in cancer | 116/4205 | 193/8465 | 2.08e-03 | 5.95e-03 | 3.05e-03 | 116 |
hsa0520213 | Esophagus | ESCC | Transcriptional misregulation in cancer | 116/4205 | 193/8465 | 2.08e-03 | 5.95e-03 | 3.05e-03 | 116 |
hsa0520221 | Prostate | Tumor | Transcriptional misregulation in cancer | 59/1791 | 193/8465 | 1.22e-03 | 5.26e-03 | 3.26e-03 | 59 |
hsa0520231 | Prostate | Tumor | Transcriptional misregulation in cancer | 59/1791 | 193/8465 | 1.22e-03 | 5.26e-03 | 3.26e-03 | 59 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HOXA10 | insertion | Frame_Shift_Ins | novel | c.974_975insCAAAT | p.Glu325AspfsTer3 | p.E325Dfs*3 | P31260 | protein_coding | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
HOXA10 | SNV | Missense_Mutation | novel | c.77C>T | p.Ala26Val | p.A26V | P31260 | protein_coding | deleterious(0.01) | probably_damaging(0.949) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
HOXA10 | SNV | Missense_Mutation | novel | c.617N>A | p.Ser206Asn | p.S206N | P31260 | protein_coding | tolerated(0.51) | benign(0) | TCGA-C5-A902-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
HOXA10 | SNV | Missense_Mutation | novel | c.1048G>A | p.Glu350Lys | p.E350K | P31260 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-VS-A9UU-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
HOXA10 | SNV | Missense_Mutation | novel | c.498G>T | p.Glu166Asp | p.E166D | P31260 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
HOXA10 | SNV | Missense_Mutation | c.1174N>C | p.Lys392Gln | p.K392Q | P31260 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CK-6746-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
HOXA10 | SNV | Missense_Mutation | novel | c.1186C>G | p.Arg396Gly | p.R396G | P31260 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
HOXA10 | SNV | Missense_Mutation | novel | c.1094G>A | p.Arg365Gln | p.R365Q | P31260 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
HOXA10 | SNV | Missense_Mutation | c.1079A>G | p.Tyr360Cys | p.Y360C | P31260 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
HOXA10 | SNV | Missense_Mutation | novel | c.1176N>T | p.Lys392Asn | p.K392N | P31260 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |